Neuroprotective Potential of Carnosine in Cerebrovascular Diseases

被引:0
|
作者
Neelakandan, A. R. [1 ]
Bae, Ok-Nam [2 ,3 ]
Majid, Arshad [4 ]
Burak, Caglayan A. [5 ]
Rajanikant, G. K. [1 ]
机构
[1] Natl Inst Technol Calicut, Sch Biotechnol, Calicut 673601, Kerala, India
[2] Hanyang Univ, Coll Pharm, Ansan 15588, South Korea
[3] Hanyang Univ, Inst Pharmaceut Sci & Technol, Ansan 15588, South Korea
[4] Univ Sheffield, Sheffield Inst Translat Neurosci SITraN, Dept Neurosci, Sheffield S10 2HQ, S Yorkshire, England
[5] Istanbul Medipol Univ, Regenerat & Restorat Med Res Ctr, Ekinciler Cad 19, TR-34810 Istanbul, Turkey
关键词
Carnosine; Ischemic stroke; Hemorrhagic stroke; Vascular dementia; Neuroprotection; CHRONIC CEREBRAL HYPOPERFUSION; ISCHEMIC NEURONAL DAMAGE; WHITE-MATTER DAMAGE; OXIDATIVE STRESS; GLOBAL BURDEN; CELL-DEATH; ENDOGENOUS NEUROPROTECTOR; INTRACEREBRAL HEMORRHAGE; SUBARACHNOID HEMORRHAGE; INDUCED NEUROTOXICITY;
D O I
10.1007/s10989-021-10342-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The growing prevalence, the risk of disabilities, and the lack of effective causal or disease-modifying therapies make cerebrovascular disorders a serious burden. Carnosine, an evolutionarily conserved endogenous dipeptide and over-the-counter food supplement, has a wealth of evidence exhibiting potentially neuroprotective effects. It is a natural, multi-functional, non-toxic anti-glycating antioxidant found in high concentrations in human and mammalian muscle and brain tissues. The physiological presence of carnosine in the brain, ability to cross the blood-brain barrier, and evidence from in vitro, and in vivo studies all point to it as a promising neurotherapeutic agent for cerebrovascular disorders. This review is intended to provide a detailed overview of the neuroprotective role of carnosine in cerebrovascular diseases and summarize existing evidence from cell and animal studies.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Potential mechanisms of cerebrovascular diseases in COVID-19 patients
    Manxue Lou
    Dezhi Yuan
    Shengtao Liao
    Linyan Tong
    Jinfang Li
    Journal of NeuroVirology, 2021, 27 : 35 - 51
  • [22] Therapeutic Potential of Hydroxysafflor Yellow A on Cardio-Cerebrovascular Diseases
    Bai, Xue
    Wang, Wen-Xiao
    Fu, Rui-Jia
    Yue, Shi-Jun
    Gao, Huan
    Chen, Yan-Yan
    Tang, Yu-Ping
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [24] The Potential Use of Honey as a Neuroprotective Agent for the Management of Neurodegenerative Diseases
    Fadzil, Mohammad Adi Mohammad
    Mustar, Suraiami
    Rashed, Aswir Abd
    NUTRIENTS, 2023, 15 (07)
  • [25] Marine Macroalgae Polyphenols as Potential Neuroprotective Antioxidants in Neurodegenerative Diseases
    Lomartire, Silvia
    Goncalves, Ana M. M.
    MARINE DRUGS, 2023, 21 (05)
  • [26] MITOCHONDRIAL DYSFUNCTIONS IN NEURODEGENERATIVE DISEASES: POTENTIAL TARGET FOR NEUROPROTECTIVE DRUGS
    Greda, Anna
    Jantas, Danuta
    POSTEPY BIOLOGII KOMORKI, 2012, 39 (03) : 321 - 344
  • [27] Cerebrovascular diseases
    Kuhlencordt, P. J.
    Roeling, J.
    Hoffmann, U.
    INTERNIST, 2009, 50 (08): : 945 - +
  • [28] Cerebrovascular diseases
    Patrizia Pantano
    Porzia Totaro
    Eytan Raz
    Neurological Sciences, 2008, 29 : 314 - 318
  • [29] Cerebrovascular diseases
    Pantano, Patrizia
    Totaro, Porzia
    Raz, Eytan
    NEUROLOGICAL SCIENCES, 2008, 29 (Suppl 3) : S314 - S318
  • [30] Analysis of cerebrovascular and neuroprotective effects of afobazole
    Silkina, IV
    Alexandrin, VV
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S243 - S244